Clinical Trials on Asthma Exacerbation in Japan

Total 113 results

University of Jazan

Completed

Comparison of Active Cycle of Breathing Technique and Pursed Lip Breathing With TheraPep

Chronic Obstructive Pulmonary Disease Exacerbation

Saudi Arabia
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)

Bronchial Asthma

Japan
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

Bronchial Asthma

Japan
Gunma University

Completed

Safety and Efficacy of High-dose Leukocytapheresis Using a Large Filter in Refractory Asthma

Bronchial Asthma

Japan
GlaxoSmithKline

Completed

A Study of GW685698X in Healthy Japanese Male Subjects

Asthma

Japan
GlaxoSmithKline

Completed

Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma

Bronchial Asthma

Japan
GlaxoSmithKline

Completed

Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-

Bronchial Asthma

Japan
AstraZeneca
Amgen

Completed

Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma (NOZOMI)

Severe Asthma

Japan
AstraZeneca

Terminated

A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

Inadequately Controlled Asthma

Japan
Novartis
Daiichi Sankyo Co., Ltd.

Completed

Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.

Asthma

Japan
Boehringer Ingelheim

Completed

Specific Use-Result of Spiriva Respimat® in Asthmatics

Asthma

Japan
Kurume University

Unknown

Effects of Montelukast on Airway Regulatory T Cells in Asthma

Asthma

Japan
AstraZeneca

Completed

To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study

Asthma

Japan
AstraZeneca

Completed

Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database (HAYATE)

Asthma

Japan
Hamamatsu University

Completed

Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients

Asthma

Japan
AstraZeneca

Completed

Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma

Asthma

Japan
Hamamatsu University

Completed

Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

Asthma

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma

Asthma

Japan
GlaxoSmithKline

Completed

Arnuity® Ellipta® Drug Use Investigation

Asthma

Japan
AstraZeneca

Completed

Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma

Asthma

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma

Asthma

Japan
AstraZeneca

Completed

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

Asthma

Japan
Kyorin Pharmaceutical Co.,Ltd

Completed

Survey on the Effect of Health Related Quality of Life (QOL) Associated With Compliance of Carbocisteine in Asthma Patients

Asthma

Japan
Satoshi Kusuda
Scientific Committee of Recurrent Wheezing

Completed

Effect of Palivizumab on Later Recurrent Wheezing in Preterm Infants

Asthma | Wheezing | Recurrent Wheezing

Japan
Eisai Co., Ltd.

Completed

Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

Chronic Obstructive Pulmonary Disease | Asthma

Japan
AstraZeneca

Recruiting

TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)

Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)

Japan
Novartis Pharmaceuticals

Completed

Dose Ranging Study for Indacaterol in Japanese Asthma Patients

Asthma

Japan
GlaxoSmithKline
Q2 Solutions; York Bioanalytical Solution; BI Medical.Inc; SRL Mediserch.Inc; Parexel...

Completed

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

Asthma

Japan
AstraZeneca

Completed

Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients

Asthma

Japan
Novartis Pharmaceuticals

Completed

Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children

Allergic Asthma

Japan
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)

Allergic Asthma

Japan
AstraZeneca

Completed

Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation (PEACE-Peds)

Bronchial Asthma

Japan
AstraZeneca
PPD; Parexel; Covance; Iqvia Pty Ltd

Completed

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma (TATE)

Severe Uncontrolled Asthma

United States, Japan
AstraZeneca

Completed

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Bronchial Asthma

Japan
AstraZeneca

Completed

Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation (ENSURE)

Bronchial Asthma

Japan
AstraZeneca

Completed

Symbicort Turbuhaler 30/60 Clinical Experience Investigation (SURE)

Bronchial Asthma

Japan
GlaxoSmithKline

Completed

A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

Asthma

Japan
GlaxoSmithKline

Completed

A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma

Asthma

Japan
AstraZeneca

Completed

Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma

Asthma

Japan
Kyowa Kirin Co., Ltd.

Completed

A Phase IIa Study of KHK4563 (4563-003)

Uncontrolled and Suspected Eosinophilic Asthma

Korea, Republic of, Japan
GlaxoSmithKline

Completed

Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma

Asthma

Japan
AstraZeneca

Completed

RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps. (RANS)

Nasal Polyps | Severe Eosinophilic Asthma

United States, France, Italy, Spain, Germany, Japan
AstraZeneca

Active, not recruiting

FASENRA SCEI for Long-term Use

Asthma

Japan
GlaxoSmithKline

Completed

Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children

Asthma

Japan, United States, United Kingdom, Poland
AstraZeneca

Completed

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

Asthma

Japan
AstraZeneca

Completed

A Study to Compare Severe Asthma Patients Who Start Biologics and Who do Not Start (PROSPECT)

Asthma

Japan
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Moderate to Severe Asthma

Korea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
Novartis Pharmaceuticals

Completed

A Long-term Safety Study of QMF149 in Japanese Participants With Asthma

Asthma

Japan
AstraZeneca

Completed

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients (Sweapea)

Asthma Patients

United States, Mexico, Russian Federation, South Africa, Romania, Ukraine, Japan, Argentina, Slovakia, Brazil
AstraZeneca

Recruiting

Tezepelumab PRO Study (TezepelumabPRO)

Asthma

Japan

3

Subscribe